Page last updated: 2024-10-24

positive regulation of humoral immune response

Definition

Target type: biologicalprocess

Any process that activates or increases the frequency, rate, or extent of a humoral immune response. [GOC:add]

Positive regulation of humoral immune response is a complex biological process that involves a coordinated interplay of various cells and molecules to enhance the production of antibodies by B cells. This process is essential for the body's defense against pathogens, particularly those that circulate in the blood and lymph. Here is a detailed description of the key steps involved:

1. **Antigen Recognition:** The process begins when B cells encounter antigens, which are foreign molecules that trigger an immune response. B cells possess specific antigen receptors (B cell receptors, BCRs) on their surface that recognize and bind to specific antigens.

2. **Antigen Presentation:** Upon antigen binding, B cells process and present fragments of the antigen to T helper cells (Th cells), specifically Th2 cells. This antigen presentation occurs through the interaction of MHC class II molecules on the B cell surface with the T cell receptor (TCR) on Th2 cells.

3. **T Cell Activation and Cytokine Production:** The interaction between B cells and Th2 cells results in the activation of Th2 cells. Activated Th2 cells release a variety of cytokines, including interleukin-4 (IL-4), interleukin-5 (IL-5), and interleukin-10 (IL-10), which play crucial roles in promoting humoral immunity.

4. **B Cell Proliferation and Differentiation:** IL-4 produced by Th2 cells acts on B cells, stimulating their proliferation and differentiation into antibody-secreting plasma cells. IL-5 further promotes the differentiation of B cells into plasma cells, while IL-10 helps to regulate the immune response and prevent excessive inflammation.

5. **Antibody Production:** Plasma cells are specialized B cells that secrete large quantities of antibodies into the bloodstream. Antibodies are Y-shaped proteins that bind specifically to antigens, neutralizing their activity and marking them for destruction by other immune cells.

6. **Antibody-Mediated Immunity:** Antibodies contribute to humoral immunity by:
* **Neutralization:** Blocking the ability of pathogens to infect cells.
* **Opsonization:** Coating pathogens with antibodies to enhance their recognition and destruction by phagocytes (immune cells that engulf and destroy pathogens).
* **Complement Activation:** Triggering the complement system, a cascade of proteins that can directly kill pathogens or enhance their opsonization and phagocytosis.

7. **Memory Cell Formation:** During the immune response, a subset of B cells differentiate into memory B cells. These cells persist in the body for extended periods, providing long-lasting immunity against specific antigens. Upon re-exposure to the same antigen, memory B cells rapidly activate and produce antibodies, allowing for a faster and more robust immune response.

Overall, positive regulation of humoral immune response is a precisely coordinated process that involves antigen recognition, T cell activation, B cell proliferation and differentiation, antibody production, and the generation of memory cells. This intricate interplay of cells and molecules ensures an effective and specific defense against a wide range of pathogens.'
"

Proteins (1)

ProteinDefinitionTaxonomy
C-C chemokine receptor type 7A C-C chemokine receptor type 7 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P32248]Homo sapiens (human)

Compounds (2)

CompoundDefinitionClassesRoles
tak 779
cenicriviroccenicriviroc : A member of the class of benzazocines that is (5Z)-1,2,3,4-tetrahydro-1-benzazocine which is substituted by a 2-methylpropyl, N-{4-[(S)-(1-propyl-1H-imidazol-5-yl)methanesulfinyl]phenyl}carboxamide and 4-(2-butoxyethoxy)phenyl groups at positions 1, 5 and 8, respectively. It is a potent chemokine 2 and 5 receptor antagonist currently in development for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis (NASH).

cenicriviroc: an inhibitor of HIV-1
aromatic ether;
benzazocine;
diether;
imidazoles;
secondary carboxamide;
sulfoxide
anti-HIV agent;
anti-inflammatory agent;
antirheumatic drug;
chemokine receptor 2 antagonist;
chemokine receptor 5 antagonist